Annual ROE
3.37%
-59.73%-94.66%
December 31, 2023
Summary
- As of February 8, 2025, KNSA annual return on equity is 3.37%, with the most recent change of -59.73% (-94.66%) on December 31, 2023.
- During the last 3 years, KNSA annual ROE has risen by +55.11% (+106.51%).
- KNSA annual ROE is now -96.38% below its all-time high of 93.16%, reached on December 31, 2016.
Performance
KNSA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-2.11%
+0.30%+12.45%
September 30, 2024
Summary
- As of February 8, 2025, KNSA quarterly return on equity is -2.11%, with the most recent change of +0.30% (+12.45%) on September 30, 2024.
- Over the past year, KNSA quarterly ROE has dropped by -0.43% (-25.60%).
- KNSA quarterly ROE is now -102.92% below its all-time high of 72.32%, reached on December 31, 2017.
Performance
KNSA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
KNSA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -94.7% | -25.6% |
| 3 y3 years | +106.5% | +96.9% |
| 5 y5 years | +109.1% | +96.6% |
KNSA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -94.7% | +105.3% | -103.0% | +97.0% |
| 5 y | 5-year | -94.7% | +104.7% | -103.0% | +97.0% |
| alltime | all time | -96.4% | +104.7% | -102.9% | +98.4% |
Kiniksa Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -2.11%(-12.4%) |
| Jun 2024 | - | -2.41%(-215.9%) |
| Mar 2024 | - | 2.08%(-39.7%) |
| Dec 2023 | 3.37%(-94.7%) | 3.45%(-305.4%) |
| Sep 2023 | - | -1.68%(-102.5%) |
| Jun 2023 | - | 66.63%(+1.2%) |
| Mar 2023 | - | 65.87%(-7.7%) |
| Dec 2022 | 63.10%(-199.3%) | 71.35%(+10.4%) |
| Sep 2022 | - | 64.64%(-210.1%) |
| Jun 2022 | - | -58.70%(-5.9%) |
| Mar 2022 | - | -62.35%(-10.6%) |
| Dec 2021 | -63.55% | -69.76%(+2.7%) |
| Sep 2021 | - | -67.90%(+6.0%) |
| Jun 2021 | - | -64.08%(+3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -61.92%(+8.1%) |
| Dec 2020 | -51.74%(-27.9%) | -57.29%(+6.8%) |
| Sep 2020 | - | -53.65%(+2.0%) |
| Jun 2020 | - | -52.59%(+2.9%) |
| Mar 2020 | - | -51.11%(-16.4%) |
| Dec 2019 | -71.81%(+94.3%) | -61.14%(-1.5%) |
| Sep 2019 | - | -62.05%(+7.7%) |
| Jun 2019 | - | -57.63%(+17.3%) |
| Mar 2019 | - | -49.12%(+36.3%) |
| Dec 2018 | -36.96%(-151.1%) | -36.05%(-25.0%) |
| Sep 2018 | - | -48.09%(-13.7%) |
| Jun 2018 | - | -55.71%(-57.5%) |
| Mar 2018 | - | -131.15%(-281.3%) |
| Dec 2017 | 72.32%(-22.4%) | 72.32% |
| Dec 2016 | 93.16% | - |
FAQ
- What is Kiniksa Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual ROE year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly ROE year-on-year change?
What is Kiniksa Pharmaceuticals annual return on equity?
The current annual ROE of KNSA is 3.37%
What is the all time high annual ROE for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual return on equity is 93.16%
What is Kiniksa Pharmaceuticals annual ROE year-on-year change?
Over the past year, KNSA annual return on equity has changed by -59.73% (-94.66%)
What is Kiniksa Pharmaceuticals quarterly return on equity?
The current quarterly ROE of KNSA is -2.11%
What is the all time high quarterly ROE for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly return on equity is 72.32%
What is Kiniksa Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, KNSA quarterly return on equity has changed by -0.43% (-25.60%)